Share

UCSD Gets go-ahead to plan new biomedical research building

UCSD has received approval from the UC Board of Regents to begin planning a new Health Sciences Biomedical Research facility on the Health Sciences campus in La Jolla. The facility is necessary to accommodate recent and projected growth in research activities in the School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences. The Regents gave a green light for planning to proceed at their March 20 meeting in San Francisco.

When complete, the proposed facility will add approximately 150,000 square feet of research and support space for UCSD Health Sciences’ substantial biomedical research programs, including a new multi-department program in genomic medicine and an expanded department of neurosciences. The architecture firm selected is Zimmer Gunsul Frasca Architects LLP.

“With the continuing success of our stellar research faculty and a number of new recruitments bringing exciting new scientific programs to our campus, our research funding has increased nearly 60 percent in the past five years,” said David A. Brenner, M.D., UCSD vice chancellor for health sciences. “First-rate, modern facilities are paramount to support our research enterprise, which is dedicated to understanding more about human disease at the fundamental level, so that we can improve the prevention, diagnosis and treatment of disease for all patients.”

The UCSD School of Medicine currently ranks 14th in the nation in National Institutes of Health research funding and consistently ranks first or second in the U.S. in research funding per faculty member. UCSD is ranked as the nation’s 5th leading public research medical school by U.S. News and World Report.

Estimated cost of the project is between $118 and $135 million. Preliminary planning for the proposed Health Sciences Biomedical Research Building will include site selection and identification of infrastructure support; determination of facility size and detailed space program; schematic design; detailed cost estimates and schedules; and identification of funding.